$CUEN
Cuentas Inc. Stock $cuen

$cuen Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024045198 Filed on May 20, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue		$639.0K	$64.00K
YoY Change		898.44%	-83.76%
Cost Of Revenue		$708.0K	$123.0K
YoY Change		475.61%	-52.69%
Gross Profit		-$69.00K	-$59.00K
YoY Change		16.95%	-144.03%
Gross Profit Margin		-10.8%	-92.19%
Selling, General & Admin		$772.0K	$1.625M
YoY Change		-52.49%	-50.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$4.000K	$2.000K
YoY Change		100.0%	-99.56%
% of Gross Profit
Operating Expenses		$774.0K	$1.627M
YoY Change		-52.43%	-56.52%
Operating Profit		-$843.0K	-$1.686M
YoY Change		-50.0%	-53.27%
Interest Expense		$5.000K	-$1.000K
YoY Change		-600.0%	0.0%
% of Operating Profit
Other Income/Expense, Net		$398.0K	$65.00K
YoY Change		512.31%
Pretax Income		-$445.0K	-$1.686M
YoY Change		-73.61%	-53.28%
Income Tax
% Of Pretax Income
Net Earnings		-$445.0K	-$1.695M
YoY Change		-73.75%	-53.23%
Net Earnings / Revenue		-69.64%	-2648.44%
Basic Earnings Per Share		-$0.15	-$1.00
Diluted Earnings Per Share		-$0.15	-$1.00
COMMON SHARES
Basic Shares Outstanding	2.730M shares	2.730M shares	2.104M shares
Diluted Shares Outstanding		2.720M shares	1.696M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.00K	$3.328M
YoY Change	-99.16%	-23.23%
Cash & Equivalents	$28.00K	$3.328M
Short-Term Investments
Other Short-Term Assets	$5.000K	$52.00K
YoY Change	-90.38%	-72.92%
Inventory
Prepaid Expenses
Receivables	$290.0K	$221.0K
Other Receivables	$459.0K	$88.00K
Total Short-Term Assets	$492.0K	$3.689M
YoY Change	-86.66%	-20.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.00K	$6.000K
YoY Change	83.33%	-33.33%
Goodwill
YoY Change
Intangibles	$17.00K	$26.00K
YoY Change	-34.62%
Long-Term Investments	$2.928M	$1.468M
YoY Change	99.46%	2230.16%
Other Assets
YoY Change
Total Long-Term Assets	$2.956M	$1.500M
YoY Change	97.07%	-70.34%
TOTAL ASSETS
Total Short-Term Assets	$492.0K	$3.689M
Total Long-Term Assets	$2.956M	$1.500M
Total Assets	$3.448M	$5.189M
YoY Change	-33.55%	-46.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.107M	$1.224M
YoY Change	72.14%	-20.36%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$163.0K	$112.0K
YoY Change	45.54%	12.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.741M	$2.221M
YoY Change	68.44%	-31.11%
LONG-TERM LIABILITIES
Long-Term Debt	$102.0K	$89.00K
YoY Change	14.61%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$102.0K	$89.00K
YoY Change	14.61%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.741M	$2.221M
Total Long-Term Liabilities	$102.0K	$89.00K
Total Liabilities	$3.843M	$2.310M
YoY Change	66.36%	-30.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$55.39M	-$54.45M
YoY Change	1.74%
Common Stock	$55.03M	$2.000K
YoY Change	2751350.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$33.00K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$395.0K	$2.879M
YoY Change
Total Liabilities & Shareholders Equity	$3.448M	$5.189M
YoY Change	-33.55%	-46.37%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$445.0K	-$1.695M
YoY Change	-73.75%	-53.23%
Depreciation, Depletion And Amortization	$4.000K	$2.000K
YoY Change	100.0%	-99.56%
Cash From Operating Activities	-$310.0K	-$1.453M
YoY Change	-78.66%	-34.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$133.0K	$4.315M
YoY Change	-96.92%
NET CHANGE
Cash From Operating Activities	-$310.0K	-$1.453M
Cash From Investing Activities
Cash From Financing Activities	$133.0K	$4.315M
Net Change In Cash	-$177.0K	$2.862M
YoY Change	-106.18%
FREE CASH FLOW
Cash From Operating Activities	-$310.0K	-$1.453M
Capital Expenditures
Free Cash Flow		-$1.453M
YoY Change		-34.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2719668	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.00
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1696022	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-39973
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	CUENTAS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3537265
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	235 Lincoln Rd.
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
CY2024Q1	dei	City Area Code CityAreaCode	800
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	611-3622
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2730058	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	205000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	7000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	76000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	492000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1760000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2928000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2928000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2956000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2960000	usd
CY2024Q1	us-gaap	Assets Assets	3448000	usd
CY2023Q4	us-gaap	Assets Assets	4720000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	163000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2107000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1497000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1012000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2230000	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	294000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	785000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	139000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	151000	usd
CY2024Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26000	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3741000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4689000	usd
CY2024Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	102000	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	101000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	102000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	101000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3843000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4790000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11076923	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2719668	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2719668	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2719668	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2719668	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	55026000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	54906000	usd
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	33000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	33000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55391000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54946000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-395000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-70000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3448000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4720000	usd
CY2024Q1	us-gaap	Revenues Revenues	639000	usd
CY2023Q1	us-gaap	Revenues Revenues	64000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	708000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	123000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-69000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-59000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	772000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1625000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	774000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1627000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-843000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1686000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	80000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	1000	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	491000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	398000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-445000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1686000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-445000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1695000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2719668	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1696022	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-70000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	120000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-445000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-395000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-724000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4319000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	700000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	136000	usd
CY2023Q1	cuen	Stock Issued During Period Value Shares Issued Due To Settlement StockIssuedDuringPeriodValueSharesIssuedDueToSettlement	120000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1695000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2879000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-445000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1695000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	120000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	283000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	5000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3000	usd
CY2023Q1	cuen	Gain From Change In On Fair Value Of Stockbased Liabilities GainFromChangeInOnFairValueOfStockbasedLiabilities	-1000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-491000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000	usd
CY2024Q1	cuen	Impairment Of Prepaid Expenses ImpairmentOfPrepaidExpenses	75000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	774000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	13000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	38000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-3000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	88000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1741000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-544000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	94000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-310000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1453000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4319000	usd
CY2024Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	150000	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	17000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	133000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4315000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-177000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2862000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	205000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	466000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3328000	usd
CY2023Q1	cuen	Issuance Of Shares Of Common Due To Acquisition Of An Asset IssuanceOfSharesOfCommonDueToAcquisitionOfAnAsset	700000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><b>NOTE 1 – GENERAL</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cuentas, Inc. (the “Company”) together with its subsidiaries, is mainly focused on financial technology (“FINTECH”) services, delivering mobile financial services, prepaid debit and digital content services to unbanked, underbanked and underserved communities. During the first quarter of 2023, the Company initiated its first investment into the Real Estate market and, made its second, more significant investment in Real Estate in the second quarter of 2023. The Company derived its revenue from wholesale telecommunication services, GPR “Debit” Card fees and the sales of prepaid products and services including third party digital content, gift cards, remittances, mobile phone topups and other digital services. Additionally, the Company has an agreement with Interactive Communications International, Inc. (“InComm”) a leading processor of general purpose reloadable (“GPR”) debit cards, to market and distribute a line of prepaid digital content and gift cards targeted towards the Latin American market. Cuentas is able to purchase InComm’s prepaid digital content and gift cards at a discount and resell these same products in real time through its mobile app and through the Cuentas SDI network of over 31,000 bodegas. Cuentas is able to offer these digital products to the public through its mobile app and the Cuentas SDI distribution network, many at discounted prices, while making a small profit margin which varies from product to product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company was incorporated under the laws of the State of Florida on September 21, 2005. Its subsidiary, Meimoun and Mammon, LLC (100% owned) (“M&M”), Tel3, a business segment of the Company, provides prepaid calling cards to consumers directly and operates in a complimentary space as Meimoun and Mammon, LLC. The Company invested $46, of which $20 were invested during 2023, for 50% of CUENTASMAX LLC which installs WiFi6 shared network (“WSN”) systems in locations in the New York metropolitan tristate area using access points and small cells to provide users with access to the WSN.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NASDAQ</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 18, 2023, the Company received a deficiency letter from Nasdaq Regulation stating that based upon its Quarterly Report on Form 10-Q for the period ended June 30, 2023 which reported shareholders’ equity of $1,471, the Company was not in compliance with Nasdaq Marketplace Rule 5550(b)(1) which requires the Company to maintain shareholders’ equity of not less than $2,500 for continued listing on The Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On October 3 2023, the Company received a Staff Determination Letter from Nasdaq Regulation stating that due to the Company’s failure by October 2, 2023, to submit a plan to regain compliance with Nasdaq Listing Rule 5550(b)(1), the $2,500 stockholders’ equity requirement, the Company would be subject to delisting unless it timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). The Company has requested a hearing before the Panel which was held on December 7, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 18, 2023, the Company received written notice from the Panel notifying the Company that the panel has determined to delist the Company’s shares and warrants from Nasdaq and that trading of its common stock and warrants will be suspended as of the opening of business on December 20, 2023. Company securities began trading on the Pink Current Information tier of the over-the-counter market operated by OTC Markets Group effective with the open of business on December 20, 2023, under its trading symbol: CUEN.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">GOING CONCERN</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of March 31, 2024, the Company had $28 in cash and cash equivalents, $3,249 in negative working capital, shareholder’s deficit of $395 and an accumulated deficit of $55,391. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. Management anticipates their business will require substantial additional investments that have not yet been secured. Management is continuing in the process of fund raising in the private equity and capital markets as the Company will need to finance future activities. The Company, through M&M is negotiating to sell mobile services as a Mobile Virtual Network Operator (“MVNO”) through an operator on the largest 5G nationwide network and plans to offer low-cost mobile phone service with the ability to make international calls to specific Spanish speaking countries in Central and South America. In addition, as noted in note 3, on March 13, 2024, the Company approved the signing of a letter of intent to sell the “Brooksville Property” for gross proceeds of $7,200 (see note 3 for further information). These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.</p>
CY2024Q1	cuen	Cuentas Sdi Network Of Over Bodegas CuentasSDINetworkOfOverBodegas	31000	pure
CY2024Q1	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	46000	usd
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	1471000	usd
CY2023Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	2500000	usd
CY2024Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On December 18, 2023, the Company received written notice from the Panel notifying the Company that the panel has determined to delist the Company’s shares and warrants from Nasdaq and that trading of its common stock and warrants will be suspended as of the opening of business on December 20, 2023.
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	28000	usd
CY2024Q1	cuen	Working Capital WorkingCapital	-3249000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-395000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55391000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7200000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	178250000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	150000000	usd
CY2024Q1	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	23250000	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	5000000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	28250000	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	1.50	pure
CY2024Q1	us-gaap	Notes Payable NotesPayable	137529000	usd
CY2023Q2	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	5050000	usd
CY2024Q1	us-gaap	Payments For Mortgage Deposits PaymentsForMortgageDeposits	3050000	usd
CY2024Q1	us-gaap	Transfer Mortgage Payable TransferMortgagePayable	3055000	usd
CY2023Q3	us-gaap	Loans Payable LoansPayable	500000	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	7200000	usd
CY2024Q2	us-gaap	Escrow Deposit EscrowDeposit	100000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	84999	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.97
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	270920	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.32
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	355919	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.07
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	355919	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.07
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.3
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	120000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	283000	usd
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	355919	shares
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	355919	shares
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	122384	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	114689	shares
CY2024Q1	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	169000	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	172000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	290000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1300000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	459000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1472000	usd
CY2024Q1	us-gaap	Revenues Revenues	639000	usd
CY2023Q1	us-gaap	Revenues Revenues	64000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-69000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-59000	usd
CY2023Q3	cuen	Initial Period By Providing A Written Notice Of Termination Days InitialPeriodByProvidingAWrittenNoticeOfTerminationDays	P90Y
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense		usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023Q1	cuen	Stock Issued During Period Value Reverse Split StockIssuedDuringPeriodValueReverseSplit		usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2024Q1	cuen	Gain From Change In On Fair Value Of Stockbased Liabilities GainFromChangeInOnFairValueOfStockbasedLiabilities		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	cuen	Impairment Of Prepaid Expenses ImpairmentOfPrepaidExpenses		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q1	cuen	Issuance Of Shares Of Common Due To Acquisition Of An Asset IssuanceOfSharesOfCommonDueToAcquisitionOfAnAsset		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001424657

Files In Submission

Name	View Source	Status
0001213900-24-045198-index-headers.html	Edgar Link	pending
0001213900-24-045198-index.html	Edgar Link	pending
0001213900-24-045198.txt	Edgar Link	pending
0001213900-24-045198-xbrl.zip	Edgar Link	pending
cuen-20240331.xsd	Edgar Link	pending
ea0206387-10q_cuentas.htm	Edgar Link	pending
ea020638701ex31-1_cuentas.htm	Edgar Link	pending
ea020638701ex31-2_cuentas.htm	Edgar Link	pending
ea020638701ex32-1_cuentas.htm	Edgar Link	pending
ea020638701ex32-2_cuentas.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
cuen-20240331_cal.xml	Edgar Link	unprocessable
cuen-20240331_def.xml	Edgar Link	unprocessable
cuen-20240331_lab.xml	Edgar Link	unprocessable
cuen-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0206387-10q_cuentas_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUEN
Cuentas Inc. Stock $cuen

2024 Q2 Form 10-Q Financial Statement

#000121390024045198 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUEN Cuentas Inc. Stock $cuen

2024 Q2 Form 10-Q Financial Statement

#000121390024045198 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUEN
Cuentas Inc. Stock $cuen